A

Addex Therapeutics Ltd

ADXN

8.26000
USD
-0.02
(-0.24%)
Market Closed
Volume
7,814
EPS
0
Div Yield
0
P/E
-1
Market Cap
10,453,686
Related Instruments
AAVEUSD
2.476
(2.16%)
117.281 USD
K
KSM
-0.04000
(-0.40%)
9.96000 USD
L
LINK
-0.03000
(-0.73%)
4.10000 USD
S
SOL
-0.07500
(-4.50%)
1.59000 USD
News

Title: Addex Therapeutics Ltd

Sector: Healthcare
Industry: Biotechnology
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.